Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF-Reference-Cited by-同舟云学术

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

Published:2004-03 Issue:6 Volume:116 Page:855-867
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Wan Paul T.C,Garnett Mathew J,Roe S.Mark,Lee Sharlene,Niculescu-Duvaz Dan,Good Valerie M,Project Cancer Genome,Jones C.Michael,Marshall Christopher J,Springer Caroline J,Barford David,Marais Richard

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference48 articles.

1. Ras activation of the Raf kinase;Avruch;Recent Prog. Horm. Res.,2001

2. Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL;Azam;Cell,2003

3. A scaleable Synthesis of BAY 43–9006;Bankston;Organic Process Res. & Dev.,2002

4. Hsp-90-associated oncoproteins;Blagosklonny;Leukemia,2002

5. BRAF and RAS mutations in human lung cancer and melanoma;Brose;Cancer Res.,2002

Cited by 2420 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical composition, cytotoxicity, and molecular docking analyses of Thuja orientalis extracts;Journal of Molecular Structure;2024-12

2. Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance;Drug Resistance Updates;2024-11

3. Cellular Senescence in Diffuse Gliomas: From Physiopathology to Possible Treatments;World Neurosurgery;2024-11

4. MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation;Cancer Letters;2024-10

5. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09